PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Eine durchschnittliche Folge dieses Podcasts dauert 19m.
Bisher sind 593 Folge(n) erschienen.
Alle 3 Tage erscheint eine Folge dieses Podcasts.
Gesamtlänge aller Episoden: 9 days 15 hours 55 minutes
Management of Patients With Untreated AML Ineligible for Intensive Remission Induction Therapy: Challenges and Opportunities
Go online to www.peervoice.com/h/pve52 to view the entire programme with slides.
Hedgehog Pathway Inhibitors for the Treatment of Advanced Basal Cell Carcinoma: Towards a Patient-Centred Approach
Go online to www.peervoice.com/h/pvr164 to view the entire programme with slides.
Current and Emerging Approaches to Viral Cure in Chronic Hepatitis B and HIV
Current and Emerging Approaches to Viral Cure in Chronic Hepatitis B and HIV
An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care
An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care
Biologic Treatment Decisions in RA: Considering Mechanisms, Evidence, and Patients
Go online to www.peervoice.com/h/pvr157 to view the entire programme with slides.
Why is There a Window of Opportunity? The Immunopathological Basis of MS
Why is There a Window of Opportunity? The Immunopathological Basis of MS
Strategic Use of ICS/LABA Combination Therapy in Asthma
Strategic Use of ICS/LABA Combination Therapy in Asthma
Antimicrobial Resistant Infections in the Acute Care Setting: Prevalence, Consequences, and Prevention Strategies
Go online to www.peervoice.com/h/pve50 to view the entire programme with slides.